Patriot Investment Management Group Inc. Has $546,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Patriot Investment Management Group Inc. lowered its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.8% in the fourth quarter, Holdings Channel reports. The firm owned 6,063 shares of the exchange traded fund’s stock after selling 375 shares during the quarter. Patriot Investment Management Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $546,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Avior Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the period. Tidemark LLC lifted its holdings in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $40,000. ORG Wealth Partners LLC acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at $44,000. Finally, Howe & Rusling Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $49,000.

SPDR S&P Biotech ETF Stock Up 1.9 %

Shares of SPDR S&P Biotech ETF stock opened at $92.98 on Friday. The company has a 50-day simple moving average of $93.33 and a two-hundred day simple moving average of $96.88. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The stock has a market capitalization of $7.09 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.